Asiaticoside alleviated NAFLD by activating Nrf2 and inhibiting the NF-κB pathway.

IF 6.7 1区医学 Q1 CHEMISTRY, MEDICINAL Phytomedicine Pub Date : 2024-12-05 DOI:10.1016/j.phymed.2024.156317

Yunfei Wei, Yibo Zhang, Baihe Zhan, Yajie Wang, Jiaqi Cheng, Hao Yu, Mengfan Lv, Yanmin Zhang, Yaxin Zhai, Yuan Guan, Haihua Feng

{"title":"Asiaticoside alleviated NAFLD by activating Nrf2 and inhibiting the NF-κB pathway.","authors":"Yunfei Wei, Yibo Zhang, Baihe Zhan, Yajie Wang, Jiaqi Cheng, Hao Yu, Mengfan Lv, Yanmin Zhang, Yaxin Zhai, Yuan Guan, Haihua Feng","doi":"10.1016/j.phymed.2024.156317","DOIUrl":null,"url":null,"abstract":"Background: Nonalcoholic fatty liver disease (NAFLD) is a globally prevalent clinical problem of chronic liver disorder whose main pathogenic mechanisms are hepatic lipid accumulation, oxidative stress, and inflammatory reactions. Asiaticoside (Asi) is a compound derived from Centella asiatica, possesses antioxidant, antiphlogistic, antifibrotic, as well as wound healing properties.Purpose: The aim of this study was to investigate the effects of Asi on NAFLD and its potential mechanisms.Study design: Two versions of experimental models were constructed using free fatty acids (FFAs)-stimulated HepG2 cells along with high-fat diet (HFD)-incited NAFLD in mice.Methods: The pivotal action of Nrf2 was then explored using Ml-385 or Nrf2-/- mice.Results: The results indicated that Asi activated the Nrf2 to alleviate oxidative stress, inhibited the NF-κB to reduce the inflammatory response, and notably decreased lipid droplets and alleviated steatosis.Conclusion: In conclusion, Asi demonstrates a potential to activate Nrf2 as well as inhibit the NF-κB pathway, there alleviate NAFLD.","PeriodicalId":20212,"journal":{"name":"Phytomedicine","volume":"136 ","pages":"156317"},"PeriodicalIF":6.7000,"publicationDate":"2024-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Phytomedicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.phymed.2024.156317","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is a globally prevalent clinical problem of chronic liver disorder whose main pathogenic mechanisms are hepatic lipid accumulation, oxidative stress, and inflammatory reactions. Asiaticoside (Asi) is a compound derived from Centella asiatica, possesses antioxidant, antiphlogistic, antifibrotic, as well as wound healing properties.

Purpose: The aim of this study was to investigate the effects of Asi on NAFLD and its potential mechanisms.

Study design: Two versions of experimental models were constructed using free fatty acids (FFAs)-stimulated HepG2 cells along with high-fat diet (HFD)-incited NAFLD in mice.

Methods: The pivotal action of Nrf2 was then explored using Ml-385 or Nrf2^-/- mice.

Results: The results indicated that Asi activated the Nrf2 to alleviate oxidative stress, inhibited the NF-κB to reduce the inflammatory response, and notably decreased lipid droplets and alleviated steatosis.

Conclusion: In conclusion, Asi demonstrates a potential to activate Nrf2 as well as inhibit the NF-κB pathway, there alleviate NAFLD.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

积雪草苷通过激活 Nrf2 和抑制 NF-κB 通路来缓解非酒精性脂肪肝。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

文献相关原料

公司名称	产品信息	其他信息	采购帮参考价格
索莱宝	GSH
索莱宝	hematoxylin
索莱宝	DAPI

来源期刊

Phytomedicine 医学-药学

CiteScore

10.30

自引率

5.10%

发文量

670

审稿时长

91 days

期刊介绍： Phytomedicine is a therapy-oriented journal that publishes innovative studies on the efficacy, safety, quality, and mechanisms of action of specified plant extracts, phytopharmaceuticals, and their isolated constituents. This includes clinical, pharmacological, pharmacokinetic, and toxicological studies of herbal medicinal products, preparations, and purified compounds with defined and consistent quality, ensuring reproducible pharmacological activity. Founded in 1994, Phytomedicine aims to focus and stimulate research in this field and establish internationally accepted scientific standards for pharmacological studies, proof of clinical efficacy, and safety of phytomedicines.